AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 296: L320-L327, 2009. First published December 19, 2008; doi:10.1152/ajplung.90485.2008
1040-0605/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/L320    most recent
90485.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, W.
Right arrow Articles by Blackwell, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, W.
Right arrow Articles by Blackwell, T. S.

Myeloid cells control termination of lung inflammation through the NF-{kappa}B pathway

Wei Han,1 Myungsoo Joo,1 M. Brett Everhart,2 John W. Christman,5 Fiona E. Yull,3 and Timothy S. Blackwell1,2,3,4

1Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, 2Department of Cell and Developmental Biology, and 3Department of Cancer Biology, Vanderbilt University School of Medicine, and 4Department of Veterans Affairs, Nashville, Tennessee; and 5Section of Pulmonary, Critical Care, and Sleep Medicine, University of Illinois at Chicago, Chicago, Illinois

Submitted 16 September 2008 ; accepted in final form 16 December 2008

Although acute lung inflammation in response to local or systemic infection involves myeloid and nonmyeloid cells, the interplay between different cell types remains poorly defined. Since NF-{kappa}B is a key transcription factor for innate immunity, we investigated whether dysregulated NF-{kappa}B activation in myeloid cells impacts inflammatory signaling in nonmyeloid cells and generation of neutrophilic lung inflammation in response to systemic endotoxemia. We generated bone marrow chimeras by fetal liver transplantation of cells deficient in I{kappa}B{alpha} or p50 into lethally irradiated NF-{kappa}B reporter transgenic mice. No differences were apparent between bone marrow chimeras in the absence of an inflammatory stimulus; however, following intraperitoneal injection of Escherichia coli lipopolysaccharide (LPS), I{kappa}B{alpha}- or p50-deficient bone marrow chimeras showed increased NF-{kappa}B activation in nonhematopoietic cells, exaggerated neutrophilic inflammation, and higher mortality compared with untransplanted reporter mice and wild-type bone marrow chimeras. Primary bone marrow-derived macrophages (BMDM) from I{kappa}B{alpha}–/– or p50–/– exhibited increased NF-{kappa}B activation and macrophage inflammatory protein-2 production after LPS treatment compared with wild-type cells, and coculture of BMDM with lung epithelial (A549) cells resulted in increased NF-{kappa}B activation in A549 cells and excess IL-8 production by these epithelial cells. These studies indicate an important role for inhibitory members of the NF-{kappa}B family acting specifically within myeloid cells to limit inflammatory responses in the lungs.

macrophage; neutrophil; acute respiratory distress syndrome; chemokine; endotoxin



Address for reprint requests and other correspondence: T. S. Blackwell, Vanderbilt Univ. School of Medicine, T-1218 MCN, Nashville, TN 37232-2650 (e-mail: timothy.blackwell{at}vanderbilt.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.